We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

Genoa, Italy Google Maps

Head of nuclear energy company shot in Genoa

Nuclear energy CEO was wounded as he left his home this morning.

THE HEAD OF AN Italian nuclear energy company has been shot and wounded outside his home in Genoa, according to Italian authorities.

Roberto Adinolfi is the CEO of Ansaldo Nuclear, a division of the state-controlled Finmeccanica company. The organisation has designed nuclear energy production facilities in China, Romania and the Czech Republic.

Adinolfi was shot in the leg by a gunman as he left his home this morning and has undergone surgery. His injuries are not believed to be serious. The gunman fled the scene on the back of a scooter.

The gunman and the person driving the scooter were both wearing helmets, La Repubblica reports, and the bike used in the attack has been found.

It is unclear who carried out today’s attack, though Italian media reports that anarchists may have been behind the shooting. Some anarchist groups had called for a change in direction that could lead to armed action, security sources were quoted.

- Additional reporting by the AP

Readers like you are keeping these stories free for everyone...
A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.

Your Voice
Readers Comments
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.